The search found 4069 results.
In 2010, the Federal Drug Enforcement Administration (DEA) published an interim final rule as to what vendors and healthcare organizations need to do to support Electronic Prescribing of Controlled Substances. Since that time many vendors have updated their solutions to meet these requirements and EPCS is slowly gaining adoption. This whitepaper simplifies the DEA ruling and identifies how to focus your planning to have a successful DEA compliant EPCS roll-out. Fill out the form below to learn more.
Key Accomplishments:
Imprivata OneSign Secure Walk-Away Integrates 3D Camera Technology, Video Tracking and Facial Recognition Software to Support HIPAA Compliance and Improve Workflow Efficiency
Reaction mixed to hydrocodone rescheduling, which will require increased security protections
A healthcare system in Michigan reports that it saves countless hours of clinicians' time by using a single sign-on system from Imprivata.